Insider Selling: Tempus AI, Inc. (NASDAQ:TEM) CAO Sells $826,200.00 in Stock

Tempus AI, Inc. (NASDAQ:TEM) CAO Ryan M. Bartolucci sold 13,770 shares of the business’s stock in a transaction that occurred on Friday, January 31st. The stock was sold at an average price of $60.00, for a total value of $826,200.00. Following the completion of the sale, the chief accounting officer now owns 57,237 shares of the company’s stock, valued at approximately $3,434,220. This trade represents a 19.39 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.

Tempus AI Trading Up 0.3 %

Shares of NASDAQ:TEM opened at $57.39 on Monday. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55. Tempus AI, Inc. has a 1-year low of $22.89 and a 1-year high of $79.49. The business’s 50 day moving average is $44.18 and its 200-day moving average is $48.29.

Institutional Investors Weigh In On Tempus AI

Several institutional investors and hedge funds have recently bought and sold shares of TEM. NEA Management Company LLC boosted its position in shares of Tempus AI by 17.8% during the 3rd quarter. NEA Management Company LLC now owns 5,385,979 shares of the company’s stock valued at $304,846,000 after acquiring an additional 813,169 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. lifted its stake in Tempus AI by 166.0% during the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,239,093 shares of the company’s stock worth $109,352,000 after purchasing an additional 2,021,394 shares during the period. ARK Investment Management LLC lifted its stake in Tempus AI by 355.0% during the third quarter. ARK Investment Management LLC now owns 2,378,157 shares of the company’s stock worth $134,604,000 after purchasing an additional 1,855,459 shares during the period. Franklin Resources Inc. boosted its holdings in Tempus AI by 1.0% during the third quarter. Franklin Resources Inc. now owns 811,311 shares of the company’s stock valued at $45,920,000 after purchasing an additional 8,387 shares in the last quarter. Finally, Millennium Management LLC bought a new stake in shares of Tempus AI in the 2nd quarter valued at approximately $8,067,000. Institutional investors own 24.22% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on TEM. Wolfe Research began coverage on shares of Tempus AI in a research note on Friday, December 13th. They issued an “outperform” rating and a $60.00 price objective for the company. Guggenheim started coverage on shares of Tempus AI in a research report on Monday, December 9th. They set a “buy” rating and a $74.00 target price for the company. Piper Sandler reaffirmed a “neutral” rating and issued a $70.00 price target (up from $40.00) on shares of Tempus AI in a research report on Tuesday, November 12th. Bank of America lifted their price objective on Tempus AI from $52.00 to $54.00 and gave the stock a “neutral” rating in a research note on Friday, December 13th. Finally, Needham & Company LLC restated a “buy” rating and set a $56.00 target price on shares of Tempus AI in a research note on Tuesday, January 14th. Three investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company. According to data from MarketBeat, Tempus AI has an average rating of “Moderate Buy” and a consensus target price of $56.36.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.